Sven Pålhagen

Selegiline slows the progression of the symptoms of Parkinson disease

Sven Pålhagen, E. H. Heinonen, J. Hägglund et al. · Neurology · 2006 · 267 citations

Medicine, Pharmacology, Pharmacotherapy +15

Euro<scp>I</scp>nf: <scp>A</scp><scp>M</scp>ulticenter <scp>C</scp>omparative <scp>O</scp>bservational <scp>S</scp>tudy of <scp>A</scp>pomorphine and <scp>L</scp>evodopa <scp>I</scp>nfusion in <scp>P</scp>arkinson's <scp>D</scp>isease

Pablo Martínez‐Martín, Prashanth Reddy, Regina Katzenschlager et al. · Movement Disorders · 2014 · 243 citations

Medicine, Pharmacology, Pharmacotherapy +11

Selegiline delays the onset of disability in de novo parkinsonian patients

Sven Pålhagen, E. H. Heinonen, J. Hägglund et al. · Neurology · 1998 · 149 citations

Medicine, Neurology, Pharmacotherapy +16

Factors of importance for weight loss in elderly patients with Parkinson's disease

Birgitta Lorefält, W. Ganowiak, Sven Pålhagen et al. · Acta Neurologica Scandinavica · 2004 · 129 citations

Medicine, Geriatric Medicine, Neurology +13

Rufinamide: a double-blind, placebo-controlled proof of principle trial in patients with epilepsy

Sven Pålhagen, R. Canger, Olaf Henriksen et al. · Epilepsy Research · 2001 · 128 citations

Medicine, Pharmacology, Pharmacotherapy +8